Chiara Burgaletto

12PUBLICATIONS
47CO-AUTHORS
Medical infection agents (incl. prions)Neurology and neuromuscular diseasesEpigenetics (incl. genome methylation and epigenomics)Nanotoxicology, health and safetyPeripheral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 09, 2026
Bone marrow myelopoiesis dysfunction in Alzheimer's disease limits monocyte homing to the brain and drives disease progression.

|Nov 28, 2025
Retinal alterations resemble brain pathology in a rat model of Parkinson's disease induced by intranigral infusion of α-synuclein oligomers.

Chiara Burgaletto, Anna Flavia Cantone, Maria Francesca Palmas

|Apr 20, 2025
Targeting CD38 immunometabolic checkpoint improves metabolic fitness and cognition in a mouse model of Alzheimer's disease.

Javier María Peralta Ramos, Giulia Castellani, Denise Kviatcovsky

|Jan 06, 2025
Monocyte-derived macrophages act as reinforcements when microglia fall short in Alzheimer's disease.

Miguel A Abellanas, Maitreyee Purnapatre, Chiara Burgaletto

|Nov 27, 2024
Correction: Musumeci et al. Intranasal Administration of a TRAIL Neutralizing Monoclonal Antibody Adsorbed in PLGA Nanoparticles and NLC Nanosystems: An In Vivo Study on a Mouse Model of Alzheimer's Disease. Biomedicines 2022, 10, 985.

Teresa Musumeci, Giulia Di Benedetto, Claudia Carbone

|Jul 10, 2024
Immune responses to oligomeric α-synuclein in Parkinson's disease peripheral blood mononuclear cells.

Ana Florencia Vega-Benedetti, Clara Porcedda, Tommaso Ercoli

Pageof 2

Frequent Collaborators

7 joint publications

Giuseppina Cantarella

4 joint publications

Michal Schwartz

3 joint publications

Carlo Maria Bellanca

3 joint publications

Antonio Munafò